The use of buprenorphine in the treatment of chronic pain in the pain clinic

被引:0
|
作者
Jakubow, Piotr [1 ,2 ,3 ]
Kosel, Dariusz [2 ,3 ]
Kosciuczyk, Urszula [2 ,3 ]
Jarocka, Malgorzata [3 ]
Kopczynska, Antonina [3 ]
Domalewska, Aneta [3 ,4 ]
Ejsmont, Anna [3 ,5 ]
机构
[1] Uniwersytet Med Bialymstoku, Zaklad Farmakol Klin, Sklodowskiej 24a, PL-15215 Bialystok, Poland
[2] Uniwersytet Med Bialymstoku, Klin Anestezjol & Intensywnej Terapii, Bialystok, Poland
[3] Poradnia Leczenia Bolu NZOZ Vitamed, Bialystok, Poland
[4] Hosp Stacjonarne Dom Opatrznosci Bozej Bialymstok, Bialystok, Poland
[5] Uniwersytet Med Bialymstoku, Klin Psychiat, Bialystok, Poland
来源
MEDYCYNA PALIATYWNA-PALLIATIVE MEDICINE | 2016年 / 8卷 / 02期
关键词
opioids; buprenorphine; noncancer pain;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: The increased use of opioids in the treatment of chronic non-cancer pain has been observed in recent years. Buprenorphine is an opioid analgesic with an established position in pain therapy. Due to the unique pharmacological profile it is attractive to use in the outpatient clinic. The big advantage of the drug is the lack of tolerance induced by opioids and, theoretically, a high safety profile. The aim of the study is to analyse the use and safety profile of buprenorphine in patients with chronic nonmalignant pain at the Outpatient Pain Treatment Clinic. Material and methods: The records of patients treated at the Outpatient Pain Treatment Clinic were subjected to a retrospective analysis, as it was reported to the National Health Fund. Results: Buprenorphine was used in 9% of patients and it represented more than 50% in the group of opioid drugs. The largest group of patients consisted of those with the back pain in the lumbosacral segment. The most demanded choice was transdermal buprenorphine. There were no serious complications or critical side effects. For 3% of patients aged 65 years and more it was necessary to reduce the dose to improve the cognitive function. Due to the skin side effects it was also necessary to rotate the transdermal formulation. Conclusions: Buprenorphine, which is preferred as the treatment of choice in chronic non-malignant pain syndromes, is also effective and safe. The dose and form of the drug should be adjusted to the state and condition of the patient.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 50 条
  • [31] Effects of opioid rotation to buprenorphine/naloxone on pain, pain thresholds, pain tolerance, and quality of life in patients with chronic pain and opioid use disorder
    Veldman, Stijn
    van Beek, Maria
    van Rijswijk, Steffie
    Ellerbroek, Hannah
    Timmerman, Hans
    van der Wal, Selina
    Steegers, Monique
    Schellekens, Arnt
    PAIN, 2022, 163 (05) : 955 - 963
  • [32] Pain severity and subsequent opioid use during buprenorphine-naloxone treatment of prescription opioid-dependent patients with chronic pain
    Weiss, Roger
    Griffin, Margaret L.
    McDermott, Katherine
    McHugh, Kathryn
    Karakula, Sterling L.
    Fitzmaurice, Garrett
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E215 - E216
  • [33] The Use of Buprenorphine to Control Cancer Pain
    Soto Nino, Maria Catalina
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2009, 13 (02): : 99 - 104
  • [34] Guideline Promoting Buprenorphine for Treatment of Chronic Pain: Transformative Yet Underdeveloped
    Cunningham, Chinazo O. O.
    Starrels, Joanna L. L.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (03) : 419 - 420
  • [35] A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain
    Gudin, Jeffrey
    Fudin, Jeffrey
    PAIN AND THERAPY, 2020, 9 (01) : 41 - 54
  • [36] Integrating Buprenorphine Into Chronic Pain Treatment-Putting the Choice in VOICE
    Incze, Michael A.
    Anderson, Timothy S.
    JAMA INTERNAL MEDICINE, 2025,
  • [37] Interviewing older men at an interdisciplinary pain clinic: the journey to chronic pain and treatment experience
    Blackbeard, David
    Aldous, Colleen
    SOUTH AFRICAN JOURNAL OF PSYCHOLOGY, 2023, 53 (04) : 576 - 588
  • [39] Treatment for cancer pain in our pain clinic
    Oda, Y
    Hosokawa, T
    Matumoto, Y
    Hirose, M
    Ohmori, M
    Hori, Y
    Tanaka, Y
    MANAGEMENT OF PAIN - A WORLD PERSPECTIVE II, VOL 1: 7TH INTERNATIONAL SYMPOSIUM - THE PAIN CLINIC, SELECTED FREE PAPERS AND POSTER PRESENTATIONS, 1996, : 89 - 93
  • [40] CHRONIC PAIN IN A PSYCHIATRIC CLINIC
    CHATURVEDI, SK
    MICHAEL, A
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 1986, 30 (03) : 347 - 354